-
E-Cigarettes Don’t Live Up to Promises
New studies find that electronic cigarettes trail other methods in helping people quit smoking, but they are growing in popularity among teens.
by Teresa Bergen
-
Forward Look
What’s NextNanoscopic biological computer kills cancer cells, spares healthy ones.
by Natalie Slivinksi
-
Forward Look
Drug Combinations for Advanced MelanomaResearchers find that when treating metastatic melanoma, timing is everything.
by Erin O'Donnell
-
Comorbidity: Treating the Whole Patient
Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
by Eric Fitzsimmons
-
From the Editor-in-Chief
RAS as an ‘Undruggable’ Drug TargetNew therapies are being developed to attack a previously untreatable cancer mutation.
by William G. Nelson, MD, PhD
-
Disparities in Cervical Cancer
Many women are being diagnosed with cervical cancer, despite the availability of tools to prevent and diagnose the disease. Black and Hispanic women and low-income and rural populations are especially vulnerable.
by Natalie Slivinski
-
A Look at Disparities Across Cancer Care
A new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.
by Eric Fitzsimmons
-
From the Editor-in-Chief
COVID-19 and Cancer in 2022Is it the beginning of the end or the end of the beginning?
by William G. Nelson, MD, PhD
-
Access to Health Insurance Key to Disparities in Cancer Outcomes
As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
by Jon Kelvey
-
Exploring Amino Acids’ Impact on Tumor Growth
Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff